Streamex Corp.
Streamex Corp. (Nasdaq: STEX) operates as a technology company with two principal lines of business: tokenized asset finance focused on digital asset and real-world asset tokenization, and biomedical technology centered on advanced signal processing solutions in electrophysiology. The company's website is… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Streamex Corp. does
In the company’s own words
Streamex Corp. (Nasdaq: STEX) operates as a technology company with two principal lines of business: tokenized asset finance focused on digital asset and real-world asset tokenization, and biomedical technology centered on advanced signal processing solutions in electrophysiology. The company's website is www.streamex.com.
The company was originally incorporated in Nevada in February 2009 and reincorporated in Delaware in April 2011. In May 2025, Streamex completed its strategic acquisition of Streamex Exchange Corporation, marking its entry into financial technology and real-world asset tokenization. This acquisition was followed by a corporate name change from BioSig Technologies, Inc. to Streamex Corp. in September 2025, with the common stock beginning to trade under the ticker symbol STEX on the Nasdaq Capital Market.
Through its Streamex division, the company operates an institutional-grade technology platform designed to enable the issuance, trading, and custody of digital tokens backed by tangible assets. The initial application focuses on tokenized gold through its GLDY product, which provides investors with digital tokens representing fractional interests in a special purpose vehicle domiciled in the Cayman Islands that holds physical gold and participates in a gold leasing program. The platform is designed to support multiple asset classes including industrial metals, energy royalties, and other real-world assets.
The company's legacy biomedical business centers on the PURE EP Platform, which delivers real-time, high-fidelity cardiac signal data to electrophysiologists during ablation procedures for treating cardiovascular arrhythmias. The company maintains majority interests in two subsidiaries: ViralClear Pharmaceuticals, Inc., approximately 69.7% owned, and BioSig AI Sciences, Inc., approximately 84.5% owned, though both subsidiaries currently have limited operational activity.
As of December 31, 2025, Streamex employed six full-time employees and engaged four consultants for specialized services. The company's intellectual property portfolio includes 46 issued or allowed utility patents, 30 pending utility patent applications, one issued and one pending artificial intelligence patent, and 30 issued worldwide design patents related to biomedical signal visualization.
Company details
- Sector
- Healthcare
- Industry
- Electromedical Apparatus
- Headquarters
- WINTER PARK, FL
- Fiscal year end
- December
- CIK
- 1530766
- SIC
- 3845
Financial performance, year by year
Fiscal 2014–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Streamex Corp. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Streamex Corp.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Streamex Corp. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Streamex Corp.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Streamex Corp.'s last four quarterly filings that the numbers alone won't show?”